IE 11 is not supported. For an optimal experience visit our site on another browser.

Melanoma Drug Shows Promise

01:36

Researchers say the drug Keytruda has been able to extend the lives of patients with advanced melanoma. Three years after being treated, 40% of patients are still alive, compared to the usual survival rate of 5%. NBC's Erika Edwards reports.